Dario Secures Second Women's Health Contract in Just Weeks with The Minnesota Star Tribune
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DarioHealth (DRIO) secured a contract expansion with The Minnesota Star Tribune to add its Dario Women program. The program is expected to become available to eligible employees in January 2027. It adds digital health support, coaching and access to licensed healthcare providers for perimenopause and menopause to DarioHealth's existing program for heart and metabolic health.
This is the second employer adoption of Dario Women within a few weeks, following a contract expansion with a regional grocery retailer. Women over age 40 account for nearly 45% of DarioHealth's current book of business. The company sees an opportunity to offer the program to more existing clients and increase revenue per customer with little additional spending to acquire customers.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.Minnesota Star Tribune contract expansion adds Dario Women, with eligible employees expected to gain access in January 2027
- Minor pointSecond employer adoption within a few weeks follows a contract expansion with a regional grocery retailer
Negative
- None.
Key Figures
- Employer adoptions
- 2
- Dario Women; within a few weeks
- Women over age 40 in current book
- Nearly 45%
- Potential existing-client adoption opportunity
- Program availability
- January 2027
- Eligible employees
Historical Context
-
Added Dario Women to retailer contract, with eligible employees offered the program in January 2027.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
perimenopause medical
menopause medical
cardiometabolic medical
hormone replacement therapy medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
New agreement reflects rapid adoption of recently launched Dario Women™, the Company's women's health solution addressing perimenopause and menopause
The Minnesota Star Tribune expands its existing relationship with Dario to amplify cardiometabolic health outcomes with comprehensive women's health support to eligible employees beginning January 2027
Nearly
The agreement marks the second employer adoption of Dario Women within just a few weeks, following the recently announced expansion with a leading regional grocery retailer. Launched just a few months ago, Dario Women is already generating commercial traction as employers recognize the need to address the health challenges many women experience during midlife and their potential impact on overall health and healthcare costs, while expanding the value of their existing multi-condition programs.
The Minnesota Star Tribune is the leading
Dario Women builds on Dario's existing cardiometabolic platform by addressing the interconnected health needs of women experiencing perimenopause and menopause. The solution combines DarioIQ's AI-driven engagement and personalization at scale with human-led behavioral coaching and access to licensed healthcare providers, including optional clinical evaluation for hormone replacement therapy when medically appropriate. The program addresses symptoms and health concerns involving weight, sleep, mood, musculoskeletal health and cardiometabolic risk.
"Women's health is an important part of supporting the overall health and well-being of our employees," said Michelle Mueller, Senior Vice President of Human Resources for The Minnesota Star Tribune. "Our experience with Dario's existing programs has demonstrated the value of accessible, personalized health support. Expanding our relationship to include Dario Women allows us to address an important and often underserved area of employee health with a solution that brings together digital engagement, coaching and clinical care."
"Securing two customers for Dario Women within weeks of one another is a strong indication that we identified an important unmet need in the market," said Erez Raphael, Chief Executive Officer of Dario. "Employers are increasingly recognizing that women's health during midlife can be closely connected to cardiometabolic conditions. By adding Dario Women to our existing multi-condition platform, we are able to address more of each member's health needs while creating additional value for our clients. Since close to
About DarioHealth Corp.
DarioHealth (Nasdaq: DRIO) is an AI-powered healthcare technology company helping health plans, health systems and employers improve health outcomes while lowering the cost of care. The Company's integrated platform combines connected devices, personalized member engagement, AI-driven insights and provider-backed clinical care to support people living with conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health needs.
Powered by more than 13 billion proprietary longitudinal healthcare data points collected over more than a decade, Dario's AI platform personalizes care at the individual member level by analyzing biometric, clinical and behavioral data to deliver more timely and effective interventions. By combining engagement, clinical intelligence and care delivery within a single platform, Dario helps customers address multiple chronic conditions through one solution.
The Minnesota Star Tribune is an innovative modern media organization building on an extraordinary 159-year legacy. With ten Pulitzer Prizes including a 2026 award for breaking news coverage, along with hundreds of other awards, the Minnesota Star Tribune boasts the Midwest's largest newsroom and is an unrivaled force for journalistic excellence in Minnesota and beyond. As the heart and voice of the north, the Minnesota Star Tribune is on a journey to create the leading model for local news in America – driving innovation in media to make every Minnesotan's life better. For more information, visit www.startribunecompany.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected launch of the program with the Minnesota Star Tribune and the timing thereof; the expectation that the program will become available and begin generating revenue in the first quarter of 2027; the ability of the agreement and the Company's relationship with the Minnesota Star Tribune to expand the Company's reach to covered lives and increase revenue per customer with minimal acquisition investment; and the scalability, growth potential and expected benefits of the Company's channel distribution strategy, platform and provider-backed care capabilities . Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
DarioHealth Corporate Contacts
Michael Lipari
SVP Corporate Development
irteam@dariohealth.com
+1-201-785-6310
Rob Halpern
SVP Marketing
irteam@dariohealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/dario-secures-second-womens-health-contract-in-just-weeks-with-the-minnesota-star-tribune-302942462.html
SOURCE DarioHealth Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.